CD25+ Cancer Research Results

CD25+, IL-2Rα interleukin-2 receptor alpha: Click to Expand ⟱

Source:

Type:

CD25, also known as interleukin-2 receptor alpha (IL-2Rα) chain, is a protein that plays a crucial role in the immune system. Primarily expressed on the surface of activated T cells, regulatory T cells (Tregs), and some types of cancer cells.

CD25+ cells have been found to be associated with various types of tumors.

Nor, Normal Healthy: Click to Expand ⟱

Normal Healthy

Scientific Papers found: Click to Expand⟱

1164-

PI,

Inhibition of T cell activation by the phytochemical piperine

in-vitro,

Nor,

*other↓, *CD25+↓, *IFN-γ↓, *IL2↓, *IL4↓, *IL17↓, *CD69↓, *CTLA-4↓, *p‑ERK↓, *IKKα↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Total Targets: 0

Pathway results for Effect on Normal Cells:

Transcription & Epigenetics ⓘ

other↓, 1,

Proliferation, Differentiation & Cell State ⓘ

p‑ERK↓, 1,

Immune & Inflammatory Signaling ⓘ

CD25+↓, 1, CD69↓, 1, CTLA-4↓, 1, IFN-γ↓, 1, IKKα↓, 1, IL17↓, 1, IL2↓, 1, IL4↓, 1,
Total Targets: 10

Scientific Paper Hit Count for: CD25+, IL-2Rα interleukin-2 receptor alpha

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells